Richard Scott Struthers, President & CEO at Crinetics Pharmaceuticals, Inc. (CRNX), bought 5,000 shares at $13.10 ($65K) on 2020-12-03, disclosed to the SEC on 2020-12-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.60 | 1,000 | $13K | 19.4% |
| 2 | $13.10 | 4,000 | $52K | 80.6% |
| Total | $13.00 avg | 5,000 | $65K | 100% |
| Filing → |
| CRNX | SELL | 2025-03-21 | $1.2M | — | Filing → |
| CRNX | SELL | 2024-12-04 | $576K | — | Filing → |
| CRNX | SELL | 2024-05-10 | $10.6M | — | Filing → |